Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy

Samsung Medical Center80 enrolled

Overview

We plan to examine genetic polymorphism of catechol-O-methyltransferase in panic disorder and neurobiological changes of panic disorder patients after 12 weeks of pharmacotherapy with paroxetine. We plan to include 40 panic disorder patients and 40 normal control subjects in this study for 3 years.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Panic Disorder

Eligibility

Sex: ALLMin age: 20 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Panic disorder Exclusion Criteria: * Other major medical or psychiatric illnesses

Locations (1)

Samsung Medical Center

Seoul, South Korea

RECRUITING

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.